Of note, all the above-mentioned responses induced by NTG were reduced/abolished by a single treatment with ADM_12, meaning that TRPA1 channels are involved in mediating glial inflammatory pathways linked to migraine pain (Figure 8). The gene discussed is TRPA1; the disease is migraine disorder.